Display options
Share it on

J Cancer. 2016 Jan 01;7(1):121-4. doi: 10.7150/jca.13377. eCollection 2016.

Radiotherapy, Bisphosphonates and Surgical Stabilization of Complete or Impending Pathologic Fractures in Patients with Metastatic Bone Disease.

Journal of Cancer

Michal J Wolanczyk, Khashayar Fakhrian, Irenäus A Adamietz

Affiliations

  1. 1. Department of General and Interventional Radiology and Neuroradiology, Wroclaw Medical University, Poland.
  2. 2. Department of Radiation Oncology, Ruhr-University of Bochum, Germany.

PMID: 26722368 PMCID: PMC4679389 DOI: 10.7150/jca.13377

Abstract

PURPOSE: To report the treatment outcomes of patients with metastatic bone disease with complete or impending pathologic fractures, who were treated with postoperative radiotherapy (RT), bisphosphonates or both after orthopedic stabilization.

MATERIAL AND METHODS: We retrospectively evaluated the results of RT, bisphosphonates or both after orthopedic stabilization for complete or impending pathologic fractures in 72 patients with skeletal metastases. After surgery, 32 patients (44%) were treated with RT alone (group 1), 31 patients (43%) were treated with RT and bisphosphonates (group 2) and 9 (13%) patients were treated with bisphosphonates (group 3), respectively. Patients were treated with a median dose of 30Gy (30-40 Gy/2-3Gy per fraction).The local tumor progression, pain progression and need for re-operation or re-radiotherapy were assessed from patients' medical records. Median follow-up time was 9 months.

RESULTS: Median overall survival time was 14 months (95% CI: 12-17). Secondary surgical intervention at the same location was necessary in 1 patient of group 1 (2%), 2 patients of group 2(5%) and 2 patients of group 3 (15%), respectively (p=0.097). Local tumor progress was observed in 3 patients of group 1 (9%), 2 patients of group 2 (7%) and 4 patients in group 3 (44%), respectively (p=0.021). Local pain progress was observed in 19%, 16% and 67% of the same groups (p=0.011).

CONCLUSION: Our data confirm the efficacy and necessity of postoperative RT after orthopedic stabilization for metastatic bone disease to control the local disease. Bisphosphonates do not obviate the need for RT in the management of bone metastases after surgical stabilization. The combined treatment might lead to a better local tumor and pain control.

Keywords: Pathological fracture; bisphosphonates; bone metastasis; orthopedic stabilization; postoperative radiotherapy

References

  1. J Clin Oncol. 2007 Apr 10;25(11):1423-36 - PubMed
  2. J Bone Joint Surg Am. 2009 Jun;91(6):1518-30 - PubMed
  3. Clin Orthop Relat Res. 2003 Oct;(415 Suppl):S158-64 - PubMed
  4. Semin Oncol. 2008 Apr;35(2):118-28 - PubMed
  5. J Hematol Oncol. 2013 Oct 23;6(1):80 - PubMed
  6. J Clin Oncol. 2008 Oct 10;26(29):4739-45 - PubMed
  7. Bull Cancer. 2001 Jul;88(7):701-7 - PubMed
  8. Clin Orthop Relat Res. 1999 Jan;(358):128-39 - PubMed
  9. Strahlenther Onkol. 1999 Oct;175(10):500-8 - PubMed
  10. Breast Care (Basel). 2012 Apr;7(2):108-112 - PubMed
  11. Instr Course Lect. 2000;49:461-70 - PubMed
  12. Int J Radiat Oncol Biol Phys. 1995 Jan 1;31(1):43-9 - PubMed
  13. Int J Radiat Oncol Biol Phys. 2003 Sep 1;57(1):143-57 - PubMed

Publication Types